Executives Leave Cassava, Maker of Controversial Alzheimer's Drug

The CEO and a chief scientist resigned just weeks after a federal grand jury brought fraud charges against a research collaborator.

Leave a Reply

Your email address will not be published. Required fields are marked *

holiganbet holiganbet giriş jojobet holiganbet giriş jojobet holiganbet giriş jojobet holiganbet giriş jojobet cratosroyalbet giriş
gaziantep escort gaziantep escort ümraniye escort ataşehir escort kadıköy escort bursa escort bursa escort bursa escort